165 related articles for article (PubMed ID: 12827058)
1. Photodynamic therapy of corneal neovascularization with verteporfin.
Fossarello M; Peiretti E; Zucca I; Serra A
Cornea; 2003 Jul; 22(5):485-8. PubMed ID: 12827058
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy with verteporfin in a rabbit model of corneal neovascularization.
Holzer MP; Solomon KD; Vroman DT; Sandoval HP; Margaron P; Kasper TJ; Crosson CE
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2954-8. PubMed ID: 12824237
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.
Schmidt-Erfurth U; Miller JW; Sickenberg M; Laqua H; Barbazetto I; Gragoudas ES; Zografos L; Piguet B; Pournaras CJ; Donati G; Lane AM; Birngruber R; van den Berg H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM
Arch Ophthalmol; 1999 Sep; 117(9):1177-87. PubMed ID: 10496389
[TBL] [Abstract][Full Text] [Related]
4. Resolution of bilateral corneal neovascularization and lipid keratopathy after photodynamic therapy with verteporfin.
Al-Abdullah AA; Al-Assiri A
Optometry; 2011 Apr; 82(4):212-4. PubMed ID: 21216676
[TBL] [Abstract][Full Text] [Related]
5. [Neovascularization corneal regression in patients treated with photodynamic therapy with verteporfin].
Díaz-Dávalos CD; Carrasco-Quiroz A; Rivera-Díez D
Rev Med Inst Mex Seguro Soc; 2016; 54(2):164-9. PubMed ID: 26960043
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy with verteporfin for corneal neovascularization.
Al-Torbak AA
Middle East Afr J Ophthalmol; 2012; 19(2):185-9. PubMed ID: 22623856
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy of pterygium with verteporfin: a preliminary report.
Fossarello M; Peiretti E; Zucca I; Perra MT; Serra A
Cornea; 2004 May; 23(4):330-8. PubMed ID: 15097125
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
[TBL] [Abstract][Full Text] [Related]
9. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.
Verteporfin In Photodynamic Therapy Study Group
Am J Ophthalmol; 2001 May; 131(5):541-60. PubMed ID: 11336929
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.
Verteporfin in Photodynamic Therapy Study Group
Ophthalmology; 2001 May; 108(5):841-52. PubMed ID: 11320011
[TBL] [Abstract][Full Text] [Related]
11. Experimental inhibition of corneal neovascularization by photodynamic therapy with verteporfin.
Yoon KC; Ahn KY; Lee SE; Kim KK; Im SK; Oh HJ; Jeong IY; Park SW; Park YG; Nah HJ; Im WB
Curr Eye Res; 2006 Mar; 31(3):215-24. PubMed ID: 16531278
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series.
Saperstein DA; Rosenfeld PJ; Bressler NM; Rosa RH; Sickenberg M; Sternberg P; Aaberg TM; Aaberg TM; Reaves TA;
Ophthalmology; 2002 Aug; 109(8):1499-505. PubMed ID: 12153802
[TBL] [Abstract][Full Text] [Related]
13. [Corneal neovascularisation treatments compared: Subconjunctival bevacizumab injections and/or photodynamic therapy].
Hamdan J; Boulze M; Aziz A; Alessi G; Hoffart L
J Fr Ophtalmol; 2015 Dec; 38(10):924-33. PubMed ID: 26522892
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy with verteporfin for corneal neovascularization.
Yoon KC; You IC; Kang IS; Im SK; Ahn JK; Park YG; Ahn KY
Am J Ophthalmol; 2007 Sep; 144(3):390-395. PubMed ID: 17631268
[TBL] [Abstract][Full Text] [Related]
15. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.
Spaide RF; Sorenson J; Maranan L
Ophthalmology; 2003 Aug; 110(8):1517-25. PubMed ID: 12917166
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic Therapy Leads to Time-Dependent Regression of Pathologic Corneal (Lymph) Angiogenesis and Promotes High-Risk Corneal Allograft Survival.
Hou Y; Le VNH; Clahsen T; Schneider AC; Bock F; Cursiefen C
Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5862-5869. PubMed ID: 29145577
[TBL] [Abstract][Full Text] [Related]
17. Recurrent herpes simplex keratitis after verteporfin photodynamic therapy for corneal neovascularization.
Yoon KC; Im SK; Park HY
Cornea; 2010 Apr; 29(4):465-7. PubMed ID: 20164757
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy with verteporfin combined with subconjunctival injection of bevacizumab for corneal neovascularization.
You IC; Im SK; Lee SH; Yoon KC
Cornea; 2011 Jan; 30(1):30-3. PubMed ID: 20861729
[TBL] [Abstract][Full Text] [Related]
19. Comparison of photodynamic therapy with two different parameters combined with subconjunctival injection of bevacizumab for corneal neovascularization.
Yin XF; Wu MH; Jin CJ; Zhou SY
Photodiagnosis Photodyn Ther; 2024 Apr; 46():104067. PubMed ID: 38548042
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.
Chan WM; Lam DS; Lai TY; Liu DT; Li KK; Yao Y; Wong TH
Ophthalmology; 2004 Aug; 111(8):1576-84. PubMed ID: 15288991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]